Joyce N. Laviscount's most recent trade in Helius Medical Technologies Inc - Ordinary Shares - Class A was a trade of 5,337 Class A Common Stock done . Disclosure was reported to the exchange on April 1, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Helius Medical Technologie... | Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 5,337 | 9,576 (0%) | 0% | 0 | Class A Common Stock | |
Helius Medical Technologie... | Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 3,490 | 3,490 | - | - | Employee Stock Option (Right to Buy) | |
Helius Medical Technologie... | Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 2,668 | 12,244 (0%) | 0% | 0 | Class A Common Stock | |
Helius Medical Technologie... | Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 21 Oct 2020 | 38,138 | 148,743 (0%) | 0% | 0.5 | 17,616 | Class A Common Stock |
Helius Medical Technologie... | Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 19,069 | 19,069 | - | - | Warrant (Right to Buy) | |
Helius Medical Technologie... | Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
Helius Medical Technologie... | Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.55 per share. | 31 Jul 2020 | 4,946 | 110,605 (0%) | 0% | 0.6 | 2,745 | Class A Common Stock |
Helius Medical Technologie... | Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.52 per share. | 15 Jul 2020 | 5,312 | 105,659 (0%) | 0% | 0.5 | 2,745 | Class A Common Stock |